LifeCell International, a leading stem cell bank, announced on Tuesday that it has raised Rs 255 crore in a fundraising round headed by OrbiMed Asia Partners IV, a healthcare investment business.
LifeCell’s founders also took part in the financing, according to a statement from the company.
Commenting on the fundraise, Mayur Abhaya, Managing Director, LifeCell International, said “We thank OrbiMed for backing LifeCell to support its growth. Having transformed the approach in cord blood stem cell preservation through its innovative community banking model, LifeCell has over the last few years undertaken several growth initiatives in genetic and genomic testing for maternal and newborn health, and innovative placental tissue-based products for wound healing.
